authors
- Hao, D
- Juergens, Rosalyn
- Laurie, S
- Mates, M
- Tehfe, M
- Bradbury, P
- Kollmannsberger, C
- Ellis, Peter
- Hilton, J
- Brown-Walker, P
- Seymour, L
A Canadian Cancer Trials Group phase IB study of durvalumab with or without tremelimumab + standard platinum-doublet chemotherapy in patients with advanced, incurable solid malignancies (IND.226)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2016
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal